Gobindgarh, Tindivanam, Mansa, Taliparamba, Manmad, Tanuku, Rayachoti, Virudhunagar, Koyilandy, Jorhat Karur, Valparai, Srikalahasti, Neyyattinkara, Bapatla, Fatehabad, Malout, Sankarankovil, Tenkasi, Ratnagiri, Rabkavi Banhatti, Sikandrabad, Chaibasa, Chirmiri, Palwancha, Bhawanipatna, Kayamkulam, Pithampur, Nabha, Shahabad, Hardoi, Dhenkanal, Uran Islampur, Gopalganj, Bongaigaon City
Meanwhile, Altimmune has repurposed its dual GLP-1/glucagon agonist, pemvidutide, in a Phase II trial focused on reducing heavy drinking days as a primary endpoint
GLP-1s appear to protect against cancer
doi:10.1111/dom.15728 ukactive
Until then, its critical for providers to connect patients with available financial resources and advocate for better coverage options